カテゴリ： 世界, 医療/バイオ, QYResearch

皮膚T細胞リンパ腫の世界市場2023年：放射線治療、幹細胞移植、局所化学療法、化学療法、免疫療法

■ 英語タイトル：Global Cutaneous Tcell Lymphoma Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7454）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7454
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[皮膚T細胞リンパ腫の世界市場2023年：放射線治療、幹細胞移植、局所化学療法、化学療法、免疫療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は皮膚T細胞リンパ腫のグローバル市場について調査・分析し、世界の皮膚T細胞リンパ腫市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（放射線治療、幹細胞移植、局所化学療法、化学療法、免疫療法）、用途別セグメント分析（病院、外来手術センター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Bristol-Myers Squibb Company、Bausch Health Companies、Kyowa Hakko Kirin、Seattle Genetics、Merck、Elorac、Actelion pharmaceuticalsなどが含まれています。皮膚T細胞リンパ腫のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、皮膚T細胞リンパ腫市場規模を算出する際に考慮しました。

・皮膚T細胞リンパ腫市場の概要
- 皮膚T細胞リンパ腫の種類別セグメント
- 世界の皮膚T細胞リンパ腫市場規模：タイプ別分析（放射線治療、幹細胞移植、局所化学療法、化学療法、免疫療法）
- 皮膚T細胞リンパ腫の用途別セグメント
- 世界の皮膚T細胞リンパ腫市場規模：用途別分析（病院、外来手術センター、その他）
- 世界の皮膚T細胞リンパ腫市場規模予測（2018年-2029年）

・皮膚T細胞リンパ腫市場の成長トレンド
- 皮膚T細胞リンパ腫の地域別市場規模（2018年-2029年）
- 皮膚T細胞リンパ腫市場ダイナミクス
- 皮膚T細胞リンパ腫の業界動向
- 皮膚T細胞リンパ腫市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：放射線治療、幹細胞移植、局所化学療法、化学療法、免疫療法
- 世界の皮膚T細胞リンパ腫のタイプ別市場規模（2018年-2023年）
- 世界の皮膚T細胞リンパ腫のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、外来手術センター、その他
- 世界の皮膚T細胞リンパ腫の用途別市場規模（2018年-2023年）
- 世界の皮膚T細胞リンパ腫の用途別市場規模（2024年-2029年）

・皮膚T細胞リンパ腫の地域別市場規模
- 北米の皮膚T細胞リンパ腫市場規模（2018年-2029年）
- 米国の皮膚T細胞リンパ腫市場規模（2018年-2029年）
- ヨーロッパの皮膚T細胞リンパ腫市場規模（2018年-2029年）
- アジア太平洋の皮膚T細胞リンパ腫市場規模（2018年-2029年）
- 中国の皮膚T細胞リンパ腫市場規模（2018年-2029年）
- 日本の皮膚T細胞リンパ腫市場規模（2018年-2029年）
- 韓国の皮膚T細胞リンパ腫市場規模（2018年-2029年）
- インドの皮膚T細胞リンパ腫市場規模（2018年-2029年）
- オーストラリアの皮膚T細胞リンパ腫市場規模（2018年-2029年）
- 中南米の皮膚T細胞リンパ腫市場規模（2018年-2029年）
- 中東・アフリカの皮膚T細胞リンパ腫市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Bristol-Myers Squibb Company、Bausch Health Companies、Kyowa Hakko Kirin、Seattle Genetics、Merck、Elorac、Actelion pharmaceuticals

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Cutaneous Tcell Lymphoma market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cutaneous Tcell Lymphoma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cutaneous Tcell Lymphoma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cutaneous Tcell Lymphoma in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cutaneous Tcell Lymphoma include Bristol-Myers Squibb Company, Bausch Health Companies, Kyowa Hakko Kirin, Seattle Genetics, Merck, Elorac and Actelion pharmaceuticals, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cutaneous Tcell Lymphoma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cutaneous Tcell Lymphoma.
The Cutaneous Tcell Lymphoma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cutaneous Tcell Lymphoma market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cutaneous Tcell Lymphoma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bristol-Myers Squibb Company
Bausch Health Companies
Kyowa Hakko Kirin
Seattle Genetics
Merck
Elorac
Actelion pharmaceuticals
Segment by Type
Radiation Therapy
Stem Cell Transplantation
Topical Chemotherapy
Chemotherapy
Immuno Therapy
Segment by Application
Hospital
Ambulatory Surgery Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cutaneous Tcell Lymphoma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Tcell Lymphoma Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiation Therapy
1.2.3 Stem Cell Transplantation
1.2.4 Topical Chemotherapy
1.2.5 Chemotherapy
1.2.6 Immuno Therapy
1.3 Market by Application
1.3.1 Global Cutaneous Tcell Lymphoma Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cutaneous Tcell Lymphoma Market Perspective (2018-2029)
2.2 Cutaneous Tcell Lymphoma Growth Trends by Region
2.2.1 Global Cutaneous Tcell Lymphoma Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cutaneous Tcell Lymphoma Historic Market Size by Region (2018-2023)
2.2.3 Cutaneous Tcell Lymphoma Forecasted Market Size by Region (2024-2029)
2.3 Cutaneous Tcell Lymphoma Market Dynamics
2.3.1 Cutaneous Tcell Lymphoma Industry Trends
2.3.2 Cutaneous Tcell Lymphoma Market Drivers
2.3.3 Cutaneous Tcell Lymphoma Market Challenges
2.3.4 Cutaneous Tcell Lymphoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Tcell Lymphoma Players by Revenue
3.1.1 Global Top Cutaneous Tcell Lymphoma Players by Revenue (2018-2023)
3.1.2 Global Cutaneous Tcell Lymphoma Revenue Market Share by Players (2018-2023)
3.2 Global Cutaneous Tcell Lymphoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Tcell Lymphoma Revenue
3.4 Global Cutaneous Tcell Lymphoma Market Concentration Ratio
3.4.1 Global Cutaneous Tcell Lymphoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Tcell Lymphoma Revenue in 2022
3.5 Cutaneous Tcell Lymphoma Key Players Head office and Area Served
3.6 Key Players Cutaneous Tcell Lymphoma Product Solution and Service
3.7 Date of Enter into Cutaneous Tcell Lymphoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cutaneous Tcell Lymphoma Breakdown Data by Type
4.1 Global Cutaneous Tcell Lymphoma Historic Market Size by Type (2018-2023)
4.2 Global Cutaneous Tcell Lymphoma Forecasted Market Size by Type (2024-2029)
5 Cutaneous Tcell Lymphoma Breakdown Data by Application
5.1 Global Cutaneous Tcell Lymphoma Historic Market Size by Application (2018-2023)
5.2 Global Cutaneous Tcell Lymphoma Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cutaneous Tcell Lymphoma Market Size (2018-2029)
6.2 North America Cutaneous Tcell Lymphoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cutaneous Tcell Lymphoma Market Size by Country (2018-2023)
6.4 North America Cutaneous Tcell Lymphoma Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cutaneous Tcell Lymphoma Market Size (2018-2029)
7.2 Europe Cutaneous Tcell Lymphoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cutaneous Tcell Lymphoma Market Size by Country (2018-2023)
7.4 Europe Cutaneous Tcell Lymphoma Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Tcell Lymphoma Market Size (2018-2029)
8.2 Asia-Pacific Cutaneous Tcell Lymphoma Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cutaneous Tcell Lymphoma Market Size by Region (2018-2023)
8.4 Asia-Pacific Cutaneous Tcell Lymphoma Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cutaneous Tcell Lymphoma Market Size (2018-2029)
9.2 Latin America Cutaneous Tcell Lymphoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cutaneous Tcell Lymphoma Market Size by Country (2018-2023)
9.4 Latin America Cutaneous Tcell Lymphoma Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Tcell Lymphoma Market Size (2018-2029)
10.2 Middle East & Africa Cutaneous Tcell Lymphoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cutaneous Tcell Lymphoma Market Size by Country (2018-2023)
10.4 Middle East & Africa Cutaneous Tcell Lymphoma Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Detail
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Cutaneous Tcell Lymphoma Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Cutaneous Tcell Lymphoma Business (2018-2023)
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Bausch Health Companies
11.2.1 Bausch Health Companies Company Detail
11.2.2 Bausch Health Companies Business Overview
11.2.3 Bausch Health Companies Cutaneous Tcell Lymphoma Introduction
11.2.4 Bausch Health Companies Revenue in Cutaneous Tcell Lymphoma Business (2018-2023)
11.2.5 Bausch Health Companies Recent Development
11.3 Kyowa Hakko Kirin
11.3.1 Kyowa Hakko Kirin Company Detail
11.3.2 Kyowa Hakko Kirin Business Overview
11.3.3 Kyowa Hakko Kirin Cutaneous Tcell Lymphoma Introduction
11.3.4 Kyowa Hakko Kirin Revenue in Cutaneous Tcell Lymphoma Business (2018-2023)
11.3.5 Kyowa Hakko Kirin Recent Development
11.4 Seattle Genetics
11.4.1 Seattle Genetics Company Detail
11.4.2 Seattle Genetics Business Overview
11.4.3 Seattle Genetics Cutaneous Tcell Lymphoma Introduction
11.4.4 Seattle Genetics Revenue in Cutaneous Tcell Lymphoma Business (2018-2023)
11.4.5 Seattle Genetics Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Cutaneous Tcell Lymphoma Introduction
11.5.4 Merck Revenue in Cutaneous Tcell Lymphoma Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Elorac
11.6.1 Elorac Company Detail
11.6.2 Elorac Business Overview
11.6.3 Elorac Cutaneous Tcell Lymphoma Introduction
11.6.4 Elorac Revenue in Cutaneous Tcell Lymphoma Business (2018-2023)
11.6.5 Elorac Recent Development
11.7 Actelion pharmaceuticals
11.7.1 Actelion pharmaceuticals Company Detail
11.7.2 Actelion pharmaceuticals Business Overview
11.7.3 Actelion pharmaceuticals Cutaneous Tcell Lymphoma Introduction
11.7.4 Actelion pharmaceuticals Revenue in Cutaneous Tcell Lymphoma Business (2018-2023)
11.7.5 Actelion pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cutaneous Tcell Lymphoma Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Stem Cell Transplantation
Table 4. Key Players of Topical Chemotherapy
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Immuno Therapy
Table 7. Global Cutaneous Tcell Lymphoma Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cutaneous Tcell Lymphoma Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Cutaneous Tcell Lymphoma Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cutaneous Tcell Lymphoma Market Share by Region (2018-2023)
Table 11. Global Cutaneous Tcell Lymphoma Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Cutaneous Tcell Lymphoma Market Share by Region (2024-2029)
Table 13. Cutaneous Tcell Lymphoma Market Trends
Table 14. Cutaneous Tcell Lymphoma Market Drivers
Table 15. Cutaneous Tcell Lymphoma Market Challenges
Table 16. Cutaneous Tcell Lymphoma Market Restraints
Table 17. Global Cutaneous Tcell Lymphoma Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cutaneous Tcell Lymphoma Market Share by Players (2018-2023)
Table 19. Global Top Cutaneous Tcell Lymphoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cutaneous Tcell Lymphoma as of 2022)
Table 20. Ranking of Global Top Cutaneous Tcell Lymphoma Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cutaneous Tcell Lymphoma Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cutaneous Tcell Lymphoma Product Solution and Service
Table 24. Date of Enter into Cutaneous Tcell Lymphoma Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cutaneous Tcell Lymphoma Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cutaneous Tcell Lymphoma Revenue Market Share by Type (2018-2023)
Table 28. Global Cutaneous Tcell Lymphoma Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Cutaneous Tcell Lymphoma Revenue Market Share by Type (2024-2029)
Table 30. Global Cutaneous Tcell Lymphoma Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cutaneous Tcell Lymphoma Revenue Market Share by Application (2018-2023)
Table 32. Global Cutaneous Tcell Lymphoma Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Cutaneous Tcell Lymphoma Revenue Market Share by Application (2024-2029)
Table 34. North America Cutaneous Tcell Lymphoma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Cutaneous Tcell Lymphoma Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cutaneous Tcell Lymphoma Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Cutaneous Tcell Lymphoma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Cutaneous Tcell Lymphoma Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cutaneous Tcell Lymphoma Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Cutaneous Tcell Lymphoma Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Cutaneous Tcell Lymphoma Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cutaneous Tcell Lymphoma Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Cutaneous Tcell Lymphoma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Cutaneous Tcell Lymphoma Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cutaneous Tcell Lymphoma Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Cutaneous Tcell Lymphoma Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Cutaneous Tcell Lymphoma Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cutaneous Tcell Lymphoma Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bristol-Myers Squibb Company Company Detail
Table 50. Bristol-Myers Squibb Company Business Overview
Table 51. Bristol-Myers Squibb Company Cutaneous Tcell Lymphoma Product
Table 52. Bristol-Myers Squibb Company Revenue in Cutaneous Tcell Lymphoma Business (2018-2023) & (US$ Million)
Table 53. Bristol-Myers Squibb Company Recent Development
Table 54. Bausch Health Companies Company Detail
Table 55. Bausch Health Companies Business Overview
Table 56. Bausch Health Companies Cutaneous Tcell Lymphoma Product
Table 57. Bausch Health Companies Revenue in Cutaneous Tcell Lymphoma Business (2018-2023) & (US$ Million)
Table 58. Bausch Health Companies Recent Development
Table 59. Kyowa Hakko Kirin Company Detail
Table 60. Kyowa Hakko Kirin Business Overview
Table 61. Kyowa Hakko Kirin Cutaneous Tcell Lymphoma Product
Table 62. Kyowa Hakko Kirin Revenue in Cutaneous Tcell Lymphoma Business (2018-2023) & (US$ Million)
Table 63. Kyowa Hakko Kirin Recent Development
Table 64. Seattle Genetics Company Detail
Table 65. Seattle Genetics Business Overview
Table 66. Seattle Genetics Cutaneous Tcell Lymphoma Product
Table 67. Seattle Genetics Revenue in Cutaneous Tcell Lymphoma Business (2018-2023) & (US$ Million)
Table 68. Seattle Genetics Recent Development
Table 69. Merck Company Detail
Table 70. Merck Business Overview
Table 71. Merck Cutaneous Tcell Lymphoma Product
Table 72. Merck Revenue in Cutaneous Tcell Lymphoma Business (2018-2023) & (US$ Million)
Table 73. Merck Recent Development
Table 74. Elorac Company Detail
Table 75. Elorac Business Overview
Table 76. Elorac Cutaneous Tcell Lymphoma Product
Table 77. Elorac Revenue in Cutaneous Tcell Lymphoma Business (2018-2023) & (US$ Million)
Table 78. Elorac Recent Development
Table 79. Actelion pharmaceuticals Company Detail
Table 80. Actelion pharmaceuticals Business Overview
Table 81. Actelion pharmaceuticals Cutaneous Tcell Lymphoma Product
Table 82. Actelion pharmaceuticals Revenue in Cutaneous Tcell Lymphoma Business (2018-2023) & (US$ Million)
Table 83. Actelion pharmaceuticals Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Tcell Lymphoma Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cutaneous Tcell Lymphoma Market Share by Type: 2022 VS 2029
Figure 3. Radiation Therapy Features
Figure 4. Stem Cell Transplantation Features
Figure 5. Topical Chemotherapy Features
Figure 6. Chemotherapy Features
Figure 7. Immuno Therapy Features
Figure 8. Global Cutaneous Tcell Lymphoma Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Cutaneous Tcell Lymphoma Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Ambulatory Surgery Center Case Studies
Figure 12. Others Case Studies
Figure 13. Cutaneous Tcell Lymphoma Report Years Considered
Figure 14. Global Cutaneous Tcell Lymphoma Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Cutaneous Tcell Lymphoma Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Cutaneous Tcell Lymphoma Market Share by Region: 2022 VS 2029
Figure 17. Global Cutaneous Tcell Lymphoma Market Share by Players in 2022
Figure 18. Global Top Cutaneous Tcell Lymphoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cutaneous Tcell Lymphoma as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cutaneous Tcell Lymphoma Revenue in 2022
Figure 20. North America Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Cutaneous Tcell Lymphoma Market Share by Country (2018-2029)
Figure 22. United States Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Cutaneous Tcell Lymphoma Market Share by Country (2018-2029)
Figure 26. Germany Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Cutaneous Tcell Lymphoma Market Share by Region (2018-2029)
Figure 34. China Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Cutaneous Tcell Lymphoma Market Share by Country (2018-2029)
Figure 42. Mexico Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Cutaneous Tcell Lymphoma Market Share by Country (2018-2029)
Figure 46. Turkey Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Cutaneous Tcell Lymphoma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Cutaneous Tcell Lymphoma Business (2018-2023)
Figure 49. Bausch Health Companies Revenue Growth Rate in Cutaneous Tcell Lymphoma Business (2018-2023)
Figure 50. Kyowa Hakko Kirin Revenue Growth Rate in Cutaneous Tcell Lymphoma Business (2018-2023)
Figure 51. Seattle Genetics Revenue Growth Rate in Cutaneous Tcell Lymphoma Business (2018-2023)
Figure 52. Merck Revenue Growth Rate in Cutaneous Tcell Lymphoma Business (2018-2023)
Figure 53. Elorac Revenue Growth Rate in Cutaneous Tcell Lymphoma Business (2018-2023)
Figure 54. Actelion pharmaceuticals Revenue Growth Rate in Cutaneous Tcell Lymphoma Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血液腫瘍薬の世界市場2023年：化学療法、標的療法、免疫療法、その他
  • レアNGR1フュージョンの世界市場2023年：免疫療法、化学療法、放射線療法
  • 血液腫瘍薬のグローバル市場展望 2023年-2029年：化学療法、標的療法、免疫療法、その他
  • ホルモン放出アゴニストのグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他
  • T細胞リンパ腫手術のグローバル市場展望 2023年-2029年：手術、幹細胞移植、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7454 )"皮膚T細胞リンパ腫の世界市場2023年：放射線治療、幹細胞移植、局所化学療法、化学療法、免疫療法" (英文：Global Cutaneous Tcell Lymphoma Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。